InsidersTradesSigma
Track the 카나프테라퓨틱스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 카나프테라퓨틱스 has logged 3 insider filings. Market capitalisation: €162bn. The latest transaction was disclosed on 23 March 2026 (Purchase). Among the most active insiders: 김동건. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Kanap Therapeutics is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.